Metadata Search Funding Data Link References Status API Help
Facet browsing currently unavailable
Page 1 of 5326 results
Sort by: relevance publication year

IKKα modulates primary sclerosing cholangitis and intrahepatic cholangiocarcinoma

JOURNAL ARTICLE published December 2014 in Journal for ImmunoTherapy of Cancer

Authors: Qun Jiang | Anthony J Scarzello | Zuoxiang Xiao | Timothy Back | Jami Willette-Brown | Feng Zhu | Yinling Hu | Robert H Wiltrout

390 A global, molecular disease characterization initiative (MDCI) in oncology clinical trials

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Melissa Johnson | Adrian Sacher | Marcus Butler | Hassane Zarour | Jeffrey Weber | Edward Garon | David Carbone | Arindam Dhar | Cristina Messina | Roma Patel | Kristin Blouch | Axel Hoos | Anne-Marie Martin

Prognostic factors related to dendritic cell vaccines on patients with advanced non-small cell lung cancers: a multicenter analysis

JOURNAL ARTICLE published December 2015 in Journal for ImmunoTherapy of Cancer

Authors: Hidenori Takahashi | Shigetaka Shimodaira | Masahiro Ogasawara | Masanori Kobayashi | Hirofumi Abe | Kazuhiro Nagai | Sunichi Tsujitani | Masato Okamoto | Yuji Morita | Yoshikazu Yonemitsu

92 Single cell and spatial multiplex profiling of immune cell markers in FFPE tumor tissues using the novel RNAscope™ HiPlex v2 in situ hybridization assay

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Sayantani Basak | Anushka Dikshit | Ming Yu | HaYeun Ji | Ching-Wei Chang | Bingqing Zhang

Four color B cell immunospot assays for simultaneous detection of all four immunoglobulin classes and subclasses

JOURNAL ARTICLE published December 2014 in Journal for ImmunoTherapy of Cancer

Authors: Richard Caspell | Fredrik Terlutter | Alexey Karulin | Paul V Lehmann

An HPV-E6/E7 immunotherapy plus PD-1 checkpoint inhibition results in tumor regression and reduction in PD-L1 expression

JOURNAL ARTICLE published December 2015 in Journal for ImmunoTherapy of Cancer

Authors: Adrian E Rice | Yvette Latchman | Joseph P Balint | John H Lee | Elizabeth S Gabitzsch | Frank R Jones

Overexpression of the cancer-related DUSP1 gene in human obesity and its modulation by physical exercise

JOURNAL ARTICLE published February 2014 in Journal for ImmunoTherapy of Cancer

Authors: Abdelkrim Khadir | Ali Tiss | Jehad Abubaker | Mohamed Abu-farha | Said Dermime | Mohammed Dehbi

Preliminary report of a clinical trial supporting the sequential use of an attenuated E39 peptide (E39') to optimize the immunologic response to the FBP (E39+GM-CSF) vaccine

JOURNAL ARTICLE published December 2015 in Journal for ImmunoTherapy of Cancer

Authors: Doreen Jackson | Na Qiao | Julia M Greene | Diane Hale | John Berry | Alfred Trappey | Timothy Vreeland | Guy Clifton | Nuhad Ibrahim | Annie Toms | George E Peoples | Elizabeth A Mittendorf

264 SIRPa blockade synergizes with radiation therapy in murine breast cancer models

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Maud Charpentier | Claire Lhuillier | Ines Mota | Sergio Trombetta | Sandra Demaria

34 Selective infiltration of Antibody-Dependent Cellular Cytoxicity (ADCC) mediating immune cells in response to treatment in a human tumor histo-culture platform

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Satish Sankaran | Nandini Pal Basak | Sindhu Govindan | BV Prakash | BV Manjula | MS Ganesh | Amritha Prabha | Kowshik Jaganathan | K Vasanth | K Gowri Shankar | A Manimaran | M Rajashekar | Ritu Malhotra | M Oliyarasi | Rachita Rao

615 Reactivating antitumor immunity in gliomas with osteopontin/integrin blocking peptide

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Paulina Pilanc-Kudlek | Katarzyna Poleszak | Aleksandra Ellert-Miklaszewska | Adria-Jaume Roura Canalda | Salwador Cyranowski | Julian Swatler | Bartłomiej Gielniewski | Bożena Kamińska

Mobilization permits reliable ELISPOT detection of long-term memory T cells secreting IFN-γ, IL-4, IL-5, and IL-17 without in vitro expansion

JOURNAL ARTICLE published November 2013 in Journal for ImmunoTherapy of Cancer

Authors: Jaya Ghosh | Alyssa Mills | Marie Wunsch | Edith Karacsony | Wenji Zhang | Jodi Hanson | Paul V Lehmann

Monitoring of immunity against leukemia stem cell in CML patients after cessation of TKI

JOURNAL ARTICLE published December 2015 in Journal for ImmunoTherapy of Cancer

Authors: Maiko Matsushita | Koji Ozawa | Saori Kanchi | Akane Uchiumi | Takuma Suzuki | Daiju Ichikawa | Eri Matsuki | Masatoshi Sakurai | Daiki Karigane | Hidenori Kasahara | Hideaki Nakajima | Shinichiro Okamoto | Yutaka Hattori

Pharmacological tumor PDL1 depletion with chlorambucil treats ovarian cancer and melanoma: improves antitumor immunity and renders anti-PDL1-resistant tumors anti-PDL1-sensitive through NK cell effects

JOURNAL ARTICLE published February 2023 in Journal for ImmunoTherapy of Cancer

Research funded by Owens Family Foundation (NA) | STARS (NA) | National Cancer Institute (CA054174,CA205965,CA239390) | Clayton Foundation (N/A) | National Institutes of Health (AG021890,GM113896,TR002647) | Dartmouth Cancer Center (Guyre Funds) | National Cancer Institute (CA268641)

Authors: Haiyan Bai | Alvaro S Padron | Yilun Deng | Yiji J Liao | Clare J Murray | Carlos Ontiveros | Suresh J Kari | Aravind Kancharla | Anand V R Kornepati | Myrna Garcia | Ryan Michael Reyes | Harshita B Gupta | Jose R Conejo-Garcia | Tyler Curiel

A phase I study of an agonist anti-CD27 human antibody (CDX-1127) in patients with advanced hematologic malignancies or solid tumors

JOURNAL ARTICLE published November 2013 in Journal for ImmunoTherapy of Cancer

Authors: Howard Burris | Stephen Ansell | John Neumanitis | Geoffrey Weiss | Branimir Sikic | Donald Northfelt | Lana Pilja | Thomas Davis | Michael Yellin | Tibor Keler | Timothy Bullock

651 Molecular signature of neoantigen-reactive CD4+ and CD8+ T cells from metastatic human cancers enables prospective antitumor TCR prediction

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Frank Lowery | Sri Krishna | Rami Yoseph | Neilesh Parikh | Praveen Chatani | Yong-Chen William Lu | Nikolaos Zacharakis | Paul Robbins | Maria Parkhurst | Steven Rosenberg

Cross-talk between CD8+ T cells and natural killers: the role of mitochondrial Aa2+ transport

JOURNAL ARTICLE published December 2014 in Journal for ImmunoTherapy of Cancer

Authors: Roman Uzhachenko | Shawn Goodwin | Menaka Thounaojam | William Hofmeister | Anil Shanker

IL-2, IL-15 and IL-21 expand T cells for targeted adoptive therapy

JOURNAL ARTICLE published 2015 in Journal for ImmunoTherapy of Cancer

Authors: Zhenjiang Liu | Qingda Meng | Markus Maeurer | Elena Rangelova | Thomas Poiret | Rebecca Robertson | Aditya Ambati | Lalit Rane | Jiri Bartek | Caroline Verbeke | Oscar Persson | Matthias Löhr | Ralf Segersvärd | Ernest Dodoo

Correction: Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumab

JOURNAL ARTICLE published October 2021 in Journal for ImmunoTherapy of Cancer

Cancer testis antigen expression in triple negative breast cancer: Candidate targets for cancer immunotherapy?

JOURNAL ARTICLE published 2015 in Journal for ImmunoTherapy of Cancer

Authors: Wouter Hendrickx | Mariam Al-Muftah | Julie Decock